VMPL
Mumbai (Maharashtra) [India], March 3: Brinton Pharmaceuticals, a prominent player in the global pharmaceutical sector, has recently inaugurated a new Sales & Marketing office in Vashi, Navi Mumbai. This development highlights the company's ongoing efforts to bolster its presence in India's rapidly growing pharmaceutical market.
The newly launched office is designed to foster collaboration, and operational efficiency, and will serve as a strategic center for Brinton's sales and marketing teams. The move aims to support the company's growth initiatives and strengthen its ability to respond to the dynamic demands of the healthcare sector. Brinton's expansion in India is part of its broader strategy to build a more agile organization, capable of adapting to the evolving needs of both healthcare professionals and consumers.
Rahul Darda, Chairman & Managing Director of Brinton Pharmaceuticals, emphasized the importance of this expansion, stating, "The new office represents a key milestone in our growth story, reflecting our commitment to operational excellence and customer-centric development. At Brinton, we understand that a thriving workplace is fundamental to our success. This new office is designed to foster collaboration, flexibility, and efficiency, enabling our teams to work together towards greater achievements."
The new office will play a crucial role in enhancing the company's engagement with customers. The move is expected to support the company's ongoing expansion of its product portfolio, in various therapeutic segments like dermatology, rheumatology, gastro and respiratory.
Brinton Pharmaceuticals is known for its high-quality, science-driven products, which have been trusted by consumers and healthcare professionals alike. With a continued focus on innovation, the company is expanding its reach across the globe, positioning itself as a leader in dermatology and skincare.
This expansion underscores Brinton's ongoing commitment to building a sustainable future in the pharmaceutical industry while reinforcing its position as a trusted name in the global healthcare landscape.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same)
